
Sign up to save your podcasts
Or


Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.
By Johns Hopkins Kimmel Cancer Center4.6
99 ratings
Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.

32,107 Listeners

41 Listeners

6 Listeners

26 Listeners

821 Listeners

4 Listeners

298 Listeners

112,918 Listeners

56,544 Listeners

324 Listeners

45 Listeners

16 Listeners

2 Listeners

25 Listeners

8,179 Listeners

625 Listeners

57,938 Listeners

156 Listeners

808 Listeners